These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8224447)

  • 21. Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models.
    Sun H; He X; Liu C; Li L; Zhou R; Jin T; Yue S; Feng D; Gong J; Sun J; Ji J; Xiang L
    ACS Chem Neurosci; 2017 Jan; 8(1):155-164. PubMed ID: 27731637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilising factor.
    Cappelletti G; Surrey T; Maci R
    FEBS Lett; 2005 Aug; 579(21):4781-6. PubMed ID: 16098973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MPP(+)-induced mitochondrial dysfunction is potentiated by dopamine.
    Boada J; Cutillas B; Roig T; Bermúdez J; Ambrosio S
    Biochem Biophys Res Commun; 2000 Feb; 268(3):916-20. PubMed ID: 10679305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential cytotoxicities of N-methyl-beta-carbolinium analogues of MPP+ in PC12 cells: insights into potential neurotoxicants in Parkinson's disease.
    Cobuzzi RJ; Neafsey EJ; Collins MA
    J Neurochem; 1994 Apr; 62(4):1503-10. PubMed ID: 8133278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins.
    Caparros-Lefebvre D; Steele J; Kotake Y; Ohta S
    Mov Disord; 2006 Oct; 21(10):1769-71. PubMed ID: 16874753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of α-melanocyte-stimulating hormone against the neurotoxicity of 1-methyl-4-phenylpyridinium.
    Peng T; Wang J; Lu J; Lu H; Teng J; Jia Y
    IUBMB Life; 2017 May; 69(5):315-320. PubMed ID: 26136377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments.
    Ravenstijn PG; Merlini M; Hameetman M; Murray TK; Ward MA; Lewis H; Ball G; Mottart C; de Ville de Goyet C; Lemarchand T; van Belle K; O'Neill MJ; Danhof M; de Lange EC
    J Pharmacol Toxicol Methods; 2008; 57(2):114-30. PubMed ID: 18155613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of PARK2 splice isoforms in an in vitro model of dopaminergic-like neurons exposed to toxic insults mimicking Parkinson's disease.
    La Cognata V; Maugeri G; D'Amico AG; Saccone S; Federico C; Cavallaro S; D'Agata V
    J Cell Biochem; 2018 Jan; 119(1):1062-1073. PubMed ID: 28688199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propofol protects against the neurotoxicity of 1‑methyl‑4‑phenylpyridinium.
    Wang S; Song T; Leng C; Lan K; Ning J; Chu H
    Mol Med Rep; 2016 Jan; 13(1):309-14. PubMed ID: 26572916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyanidin Protects SH-SY5Y Human Neuroblastoma Cells from 1-Methyl-4-Phenylpyridinium-Induced Neurotoxicity.
    Chen J; Sun J; Jiang J; Zhou J
    Pharmacology; 2018; 102(3-4):126-132. PubMed ID: 29982258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroscience. Pesticide causes Parkinson's in rats.
    Helmuth L
    Science; 2000 Nov; 290(5494):1068. PubMed ID: 11184997
    [No Abstract]   [Full Text] [Related]  

  • 32. [Proteolytic stress induced by environmental toxins in dopaminergic neurons: an experimental study].
    Wang L; Cao XB; Wang JM; Qu RS; Xu L; Qiao X; Sun SG
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(17):1190-4. PubMed ID: 17686240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.
    Chorfa A; Bétemps D; Morignat E; Lazizzera C; Hogeveen K; Andrieu T; Baron T
    Toxicol Sci; 2013 Jun; 133(2):289-97. PubMed ID: 23535362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of matrix metalloproteinase-9 gene expression in MPP+- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells.
    Kim SY; Woo MS; Park JS; Kim HS
    Neurochem Int; 2010 Feb; 56(3):437-42. PubMed ID: 19962414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.
    Offen D; Sherki Y; Melamed E; Fridkin M; Brenneman DE; Gozes I
    Brain Res; 2000 Jan; 854(1-2):257-62. PubMed ID: 10784133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and environmental factors in the pathogenesis of Parkinson's disease.
    Mizuno Y; Shimoda-Matsubayashi S; Matsumine H; Morikawa N; Hattori N; Kondo T
    Adv Neurol; 1999; 80():171-9. PubMed ID: 10410718
    [No Abstract]   [Full Text] [Related]  

  • 37. Might environmental factors contribute to neurodegenerative diseases?
    Tipton KF
    Biochem Soc Trans; 1995 May; 23(2):429-35. PubMed ID: 7672436
    [No Abstract]   [Full Text] [Related]  

  • 38. Pesticide use linked to Parkinson's disease.
    Adam D
    Nature; 2000 Nov; 408(6809):125. PubMed ID: 11089940
    [No Abstract]   [Full Text] [Related]  

  • 39. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
    Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F
    Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2,9-Dimethyl-beta-carbolinium, a neurotoxin occurring in human brain, is a potent inducer of apoptosis as 1-methyl-4-phenylpyridinium.
    Pavlovic S; Schulze G; Wernicke C; Bonnet R; Gille G; Badiali L; Kaminska A; Lorenc-Koci E; Ossowska K; Rommelspacher H
    Neuroscience; 2006; 139(4):1525-37. PubMed ID: 16517085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.